ETRETINATE BLOOD-LEVELS IN MONITORING OF COMPLIANCE AND CONTAMINATION IN A CHEMOPREVENTION TRIAL

被引：9

作者：

BROWMAN, GP

ARNOLD, A

BOOKER, L

JOHNSTONE, B

SKINGLEY, P

LEVINE, MN

机构：

[1] MCMASTER UNIV,HAMILTON CIVIC HOSP,HAMILTON L8S 4L8,ONTARIO,CANADA

[2] MCMASTER UNIV,ST JOSEPH HOSP,HAMILTON L8S 4L8,ONTARIO,CANADA

[3] ONTARIO CLIN ONCOL GRP,HAMILTON,ONTARIO,CANADA

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1989年 / 81卷 / 10期

关键词：

D O I：

10.1093/jnci/81.10.795

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：795 / 798

页数：4

相关论文

共 12 条

[1] ANALYSIS OF RETINOIDS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY USING PROGRAMMED GRADIENT SEPARATION
ANNESLEY, T
GIACHERIO, D
WILKERSON, K
GREKIN, R
ELLIS, C
[J]. JOURNAL OF CHROMATOGRAPHY, 1984, 305 (01): : 199 - 203
[2] ARNOLD A, IN PRESS PREV MED
[3] BERTRAM JS, 1987, CANCER RES, V47, P3012
[4] GOUVEIA J, 1982, LANCET, V1, P710
[5] LIPPMAN SM, 1987, CANCER TREAT REP, V71, P391
[6] MCCLEAN SW, 1982, CLIN CHEM, V28, P693
[7] MCLARTY J, 1988, 3RD P INT C PREV HUM
[8] MISSET JL, 1986, CANCER DETECT PREV, V9, P167
[9] SACKETT DL, 1979, NEW ENGL J MED, V301, P469
[10] SCHWARTZ D, 1980, CLIN TRIALS